romidepsin

Related by string. Romidepsin * * romidepsin novel *

Related by context. All words. (Click for frequent words.) 77 Romidepsin 74 cutaneous T cell 74 depsipeptide 72 alvespimycin 72 Aplidin 72 cell lymphoma CTCL 71 elotuzumab 71 Azedra 71 HuMax CD4 71 cutaneous T 71 radiation sensitizer 71 HuMax EGFr 70 ISTODAX 70 IMA# 70 lymphoma CTCL 70 MAGE A3 ASCI 70 ixabepilone 70 Xanafide 70 Traficet EN 70 Panzem R NCD 70 docetaxel Taxotere R 70 Proxinium TM 70 ganetespib 70 thymalfasin 70 FK# 69 Istodax 69 Archexin 69 Tarceva TM 69 LEUKINE 69 pomalidomide 69 tanespimycin 69 Amrubicin 69 YONDELIS 69 sorafenib Nexavar 69 ofatumumab 69 neratinib 69 eltrombopag 69 OncoVEX GM CSF 69 galiximab 69 PXD# 69 Onrigin 69 entinostat 69 Aflibercept 69 BAY #-# 69 methylnaltrexone 69 enzastaurin 69 obatoclax 69 oral prodrug 68 phase IIb clinical 68 Ceflatonin 68 rilonacept 68 amrubicin 68 EOquin TM 68 oral ridaforolimus 68 EOquin 68 PRT# 68 baminercept 68 CA4P 68 Bezielle 68 zanolimumab 68 Epratuzumab 68 sunitinib malate 68 tocilizumab 68 zalutumumab 68 thalidomide Thalomid 68 PNP inhibitor 68 ZACTIMA 68 INCB# [001] 68 HSP# inhibitor 68 Omacetaxine 68 KRN# 68 brivaracetam 68 elacytarabine 68 Vilazodone 68 HuLuc# 68 forodesine 67 deforolimus 67 Symadex 67 metaglidasen 67 CEQ# 67 rALLy clinical trial 67 sargramostim 67 ISTODAX ® 67 XmAb# 67 phase IIa clinical 67 lumiliximab 67 HQK 67 ATL/TV# 67 Amplimexon 67 Phase Ib II 67 receptor tyrosine kinase inhibitor 67 atacicept 67 relapsed multiple myeloma 67 HER2 positive metastatic breast 67 OncoVex 67 riociguat 67 varespladib 67 pertuzumab 67 GW# [003] 67 axitinib 67 phase Ib 67 MabCampath 67 OPAXIO 67 pralatrexate 67 Xerecept 67 Virulizin ® 67 Arranon 67 phase IIb trial 67 HGS ETR2 67 Phase Ib study 67 Vidaza azacitidine 67 vorinostat 67 CR# vcMMAE 67 ZYBRESTAT fosbretabulin 67 vosaroxin 67 ZYBRESTAT 67 teriflunomide 67 ADVEXIN 67 Dacogen injection 67 relapsed refractory multiple myeloma 67 metastatic hormone refractory 67 HGS# 67 Cloretazine R VNP#M 67 #I TM# 67 mertansine 67 dacetuzumab 67 oral antiviral 67 Phase Ib clinical 67 MGd 67 TELCYTA 67 Chemophase 67 PDE4 inhibitor 67 L BLP# 67 GSK# [001] 67 CIMZIA ™ 67 Cethrin 67 novel histone deacetylase 66 ELACYT 66 refractory chronic lymphocytic 66 adecatumumab 66 Bicifadine 66 mycophenolate mofetil 66 ponatinib 66 Targretin capsules 66 Glufosfamide 66 CYT# potent vascular disrupting 66 tramiprosate Alzhemed TM 66 leukemia AML 66 OMP #M# 66 PROMACTA 66 SNT MC# 66 talactoferrin 66 Pyridorin 66 bortezomib Velcade R 66 TG# [003] 66 JAK inhibitor 66 Triapine R 66 Removab 66 Pemetrexed 66 abatacept Orencia 66 mapatumumab 66 recurrent glioblastoma multiforme 66 vemurafenib 66 PEG SN# 66 relapsed MM 66 Plicera 66 pan HDAC inhibitor 66 bendamustine 66 cetuximab Erbitux R 66 preclinically 66 refractory cutaneous T 66 Cloretazine ® 66 DU #b 66 alefacept 66 efalizumab 66 mTOR inhibitor 66 nucleoside analog 66 Allovectin 7 ® 66 huN# DM1 66 subcutaneous formulation 66 docetaxel Taxotere 66 Troxatyl 66 cediranib 66 vascular disrupting agent 66 Fibrillex TM 66 DermaVir Patch 66 sapacitabine 66 reslizumab 66 evaluating tivozanib 66 TBC# 66 cilengitide 66 Tyrima 66 ENMD # 66 Annamycin 66 histone deacetylase inhibitor 66 Velcade bortezomib 66 Quinamed 66 Seliciclib 66 IL# PE#QQR 66 Firazyr 66 Aplidin R 66 vinca alkaloid 66 liposomal formulation 66 OvaRex ® MAb 66 BRIM2 66 Panzem R 66 oral salmon calcitonin 66 talabostat 66 RhuDex ® 66 lapatinib Tykerb 66 casopitant 66 docetaxel Taxotere ® 65 Triapine 65 PI3K/Akt pathway inhibitor 65 lenalidomide Revlimid R 65 indibulin 65 Pazopanib 65 aflibercept VEGF Trap 65 IAP inhibitors 65 NVA# 65 NP2 Enkephalin 65 Cloretazine R 65 ATL# [001] 65 BRAF inhibitor 65 TOCOSOL Paclitaxel 65 Cloretazine 65 Targretin 65 AEG# 65 Zoraxel 65 Allovectin 7 65 Onconase 65 trastuzumab Herceptin R 65 glufosfamide 65 vascular disrupting agents 65 ongoing Phase 1b 65 HGS ETR1 65 CYC# 65 lintuzumab 65 CIMZIA TM 65 CBLC# 65 Ophena TM 65 APOPTONE 65 FOLOTYN ® 65 regorafenib 65 ASONEP 65 oral Xeloda 65 fosbretabulin 65 calcineurin inhibitors 65 farletuzumab 65 KNS # 65 tesetaxel 65 CLORETAZINE TM VNP#M 65 histone deacetylase HDAC inhibitor 65 Herceptin trastuzumab 65 IRX 2 65 Aurexis 65 metastatic CRC 65 Phase 1b trial 65 ocrelizumab 65 recurrent GBM 65 Campath alemtuzumab 65 nab paclitaxel 65 platelet inhibitor 65 OMAPRO 65 vidofludimus 65 ZOLINZA 65 orally bioavailable 65 UPLYSO 65 demonstrated antitumor activity 65 proteasome inhibitor 65 BrachySil TM 65 TRISENOX 65 Vicinium TM 65 capecitabine Xeloda R 65 apremilast 65 vandetanib 65 GRN# 65 proteasome inhibitor bortezomib 65 blinded randomized placebo controlled 65 OXi# 65 ThermoDox R 65 RSD# oral 65 VAPRISOL 65 vicriviroc 65 Nexavar sorafenib 65 pain palliation 65 TYKERB 65 anticancer compound 65 abiraterone acetate 65 registrational 65 SAR# [004] 65 LibiGel ® 65 sorafenib tablets 65 Fludara ® 65 Phase IIb III 65 AVASTIN 65 ProMune 65 Cimzia TM 65 IMGN# 65 Carfilzomib 65 bosutinib 65 MGCD# [001] 65 Bortezomib 65 XL# XL# 65 tafamidis 65 Phase IIIb clinical 65 trastuzumab emtansine T DM1 65 REOLYSIN ® 65 Ambrisentan 65 Avastin bevacizumab 65 Daclizumab 65 PEGylated interferon beta 1a 65 Cutaneous T 64 GRNVAC1 64 diabetic neuropathic pain 64 SCH # 64 phase IIb 64 OvaRex R 64 Leukine ® 64 rasagiline tablets 64 intranasal formulation 64 virus HCV protease inhibitor 64 Evoltra ® 64 angiogenesis inhibitor 64 Mipomersen 64 OHR/AVR# 64 eniluracil 64 OncoVEX 64 FOLFOX6 64 acyclovir Lauriad R 64 TELINTRA 64 Alzhemed TM 64 Imprime PGG 64 SYN# 64 Nexavar ® 64 Zybrestat 64 rituximab Rituxan 64 atrasentan 64 VNP#M 64 bevacizumab Avastin 64 Campath ® 64 alkylating agent 64 adalimumab Humira 64 PrevOnco 64 Doxil ® 64 Xinlay 64 ACZ# 64 Degarelix 64 Reolysin 64 Torisel 64 Dabigatran etexilate 64 PANVAC VF 64 cytokine refractory 64 Revlimid lenalidomide 64 Clolar ® 64 Laquinimod 64 Dacogen decitabine 64 MyVax R 64 erlotinib Tarceva ® 64 BCX# 64 lintuzumab SGN 64 Zolinza 64 Maribavir 64 Androxal TM 64 huC# DM4 64 phase IIb study 64 OZURDEX ® 64 Genz # 64 Elotuzumab 64 Blinatumomab 64 Phase 1a clinical 64 Vitaxin 64 Myocet 64 posaconazole 64 relapsed MCL 64 metastatic renal cell carcinoma 64 midstage clinical 64 oral talactoferrin 64 subcutaneous SC 64 Aptivus ® 64 alpha 2a 64 lenalidomide dexamethasone 64 DAVANAT 64 Amigal 64 Voreloxin 64 somatostatin analogue 64 PrevOnco ™ 64 Factor VIIa 64 dasatinib Sprycel ® 64 ruxolitinib 64 PROSTVAC TM 64 ofatumumab HuMax CD# 64 Pertuzumab 64 Sapacitabine 64 Factor Xa inhibitor 64 EndoTAGTM 1 64 ularitide 64 decitabine 64 anti angiogenic agents 64 TORISEL 64 Fodosine 64 seliciclib CYC# 64 briakinumab 64 IMP# 64 Teriflunomide 64 alvimopan 64 KIACTA ™ 64 orally administered inhibitor 64 Erbitux cetuximab 64 Phase #b/#a clinical 64 Actilon 64 celgosivir 64 MEK inhibitors 64 K ras mutations 64 EndoTAG TM -1 64 Lixivaptan 64 multiple myeloma MM 64 gefitinib Iressa 64 refractory gout 64 investigational humanized monoclonal antibody 64 lasofoxifene 64 Durezol 64 Taxotere R 64 bevacizumab Avastin ® 64 FOLFOX6 chemotherapy regimen 64 palifosfamide 64 albinterferon alfa 2b 64 Golimumab 64 Romiplostim 64 Zemplar Capsules 64 refractory metastatic 64 paclitaxel Taxol ® 64 Sym# 64 torezolid phosphate 64 ProSavin 64 acute promyelocytic leukemia APL 64 Saforis 64 refractory CLL 64 AQ4N 64 Hycamtin 64 OncoGel 64 CYT# 64 multicenter Phase II 64 bazedoxifene 64 lesinurad 64 nilotinib 64 BEXXAR 64 OMNARIS HFA 64 clobazam 64 bortezomib Velcade 64 HepeX B 64 Alocrest 64 octreotide acetate 64 clofarabine 64 Teysuno 64 favorable pharmacokinetic profile 64 ONGLYZA ™ 64 CoFactor 64 AZILECT R 64 Vernakalant 64 YONDELIS R 64 CD# monoclonal antibody 64 cetuximab Erbitux ® 64 goserelin 64 trabectedin 64 Taxotere ® 64 oral deforolimus 64 anti leukemic 64 somatostatin analog 64 Dasatinib 64 rNAPc2 64 Nebido 64 anti amnesic 64 vinflunine 64 blinatumomab 64 Naproxcinod 64 Gemzar ® 64 relapsing remitting multiple sclerosis 64 MabThera rituximab 64 gemcitabine Gemzar ® 64 metastatic malignant melanoma 64 MYDICAR ® 64 Aviptadil 64 HCD# [002] 64 AP# [003] 64 BNC# 64 Vandetanib 64 novel VDA molecule 64 oral rivaroxaban 64 Xeloda ® 64 DOXIL 64 interferon gamma 1b 63 TroVax ® 63 adecatumumab MT# 63 CANCIDAS 63 Enzastaurin 63 recurrent NSCLC 63 recurrent glioblastoma 63 alagebrium 63 targeting CD# 63 PROSTVAC VF 63 fluoropyrimidine 63 CCR5 antagonist 63 OMP #R# 63 TACI Ig 63 Afatinib 63 metastatic castration resistant 63 orBec 63 Perifosine 63 Zenvia ™ 63 Muraglitazar 63 BrachySil 63 Raptiva ® 63 R#/MEM # 63 #D#C# 63 alemtuzumab Campath 63 RSR# 63 valopicitabine 63 PSMA ADC 63 Taxotere docetaxel 63 Phase #b/#a 63 omacetaxine 63 Phase 2a trial 63 ADP receptor antagonist 63 Sanofi Aventis Taxotere 63 Zarnestra 63 NXL# 63 CDP# 63 GAP #B# 63 Pivotal Phase III 63 Rebif ® 63 R sorafenib tablets 63 miconazole Lauriad ® 63 investigational protease inhibitor 63 ELND# 63 Restanza 63 small molecule Hedgehog 63 PI3K inhibitor 63 pegylated liposomal doxorubicin 63 Panzem NCD 63 IMC A# 63 Evoltra 63 investigational therapies 63 Mitoxantrone 63 ZK EPO 63 dose escalation Phase 63 Davanat 63 EFAPROXYN 63 gemcitabine Gemzar 63 Xcellerated T Cells 63 Octreolin 63 pharmacokinetic PK study 63 oxaliplatin Eloxatin 63 docetaxel chemotherapy 63 Zerenex 63 standard chemotherapy regimen 63 Phase IIb clinical trials 63 Genentech Rituxan 63 Phase 1b clinical 63 SPRYCEL ® 63 mitomycin 63 vinorelbine tartrate 63 Debio 63 pediatric acute lymphoblastic 63 Cimzia ® 63 CTAP# Capsules 63 ON #.Na 63 StemEx 63 CIMZIA TM certolizumab pegol 63 octreotide 63 Pimavanserin 63 Adentri 63 Tavocept 63 TroVax 63 volociximab 63 dasatinib Sprycel 63 Darinaparsin 63 miglustat 63 Arimoclomol 63 picoplatin 63 ONTAK 63 BENLYSTA ® 63 Dyloject TM 63 RLY# 63 AZILECT ® 63 GLYX 63 PKC# 63 XYOTAX TM 63 TEMODAL 63 sitaxsentan 63 LY# [003] 63 Neuradiab 63 TRO# 63 Apoptone 63 PEG Interferon lambda 63 PSN# [001] 63 Irinotecan 63 combretastatin A4 phosphate CA4P 63 drug ISA# 63 nonclinical studies 63 Mepact 63 subcutaneously administered 63 velaglucerase alfa 63 SinuNase TM 63 ulimorelin 63 Zingo TM 63 AAG geldanamycin analog 63 capecitabine Xeloda 63 Resten NG 63 velafermin 63 Campath 63 isoform selective 63 trastuzumab Herceptin ® 63 MNTX 63 Nimotuzumab 63 etanercept Enbrel 63 Asentar 63 IGF 1R inhibitor 63 AGGRASTAT ® 63 relapsed ovarian cancer 63 beta 1a 63 vismodegib 63 Combidex 63 Exelixis compounds 63 thetreatment 63 Nanobody 63 GATTEX ® 63 visilizumab 63 RH1 63 LymphoStat B belimumab 63 ORENCIA ® 63 Tanespimycin 63 Spiegelmer ® 63 Simulect 63 placebo controlled Phase 63 radiolabeled TM# 63 Anturol TM 63 DCCR 63 fenofibric acid 63 temsirolimus 63 tamibarotene 63 HuMax CD# 63 Revimmune 63 immune modulating 63 Catena ® 63 idarubicin 63 anticancer activity 63 trastuzumab Herceptin 63 Tesmilifene 63 mitogen activated ERK kinase 63 XERECEPT R 63 Pirfenidone 63 Phase Ib 63 Luteinizing Hormone Releasing Hormone 63 Talabostat 63 Ocrelizumab 63 ASA# 63 investigational monoclonal antibody 63 Trabectedin 63 AMEVIVE 63 belinostat 63 MYCAMINE 63 FTY# fingolimod 63 Akt inhibitor 63 Solesta 63 RAPTIVA 63 TREANDA 63 epigenetic therapies 63 DDP# 63 ZYBRESTAT TM 63 Tarvacin TM 63 phase 2a 63 selective modulator 63 orally dosed 63 dextromethorphan quinidine 63 novel oral anticoagulant 63 bicifadine 63 MEND CABG 63 lorvotuzumab mertansine 63 Leukine 63 PDX pralatrexate 63 Tasigna nilotinib 63 Eltrombopag 63 low dose cytarabine 63 Personalized Immunotherapy 63 Alpharadin 63 pexiganan 63 unique alkylating agent 63 multitargeted 63 otelixizumab 63 histamine dihydrochloride 63 Genasense ® 63 sorafenib Nexavar R 63 tezampanel 63 tipranavir 63 Ceflatonin R 63 Phase #/#a 63 Rotigotine 63 Phenoptin 63 ACTEMRA TM 63 RG# [001] 63 NEBIDO 63 prucalopride 63 DACH platinum 63 Initiates Enrollment 63 EGS# 63 pazopanib 63 eosinophilic asthma 63 omacetaxine mepesuccinate 63 TPI ASM8 63 clevidipine 63 anticancer agent 63 tesmilifene 63 Clevudine 63 ATL# [002] 63 Tarvacin 63 targeted antifolate 63 Marqibo TM 63 opioid induced bowel dysfunction 63 investigational hepatitis C 63 OvaRex MAb 63 iniparib 63 mitoxantrone plus 63 RhuDex R 63 DEB# 63 ALK inhibitor 63 Arcalyst 63 icatibant 63 ELIQUIS 63 investigational compound 63 XL# [003] 63 Taxotere chemotherapy 63 ToGA 63 Onco TCS 62 IV Busulfex 62 Plenaxis TM 62 targeted radiotherapeutic 62 Lenocta 62 antithrombotic 62 ALGRX 62 Fludara 62 LT NS# 62 selective A2A adenosine receptor 62 Lenalidomide 62 imatinib resistant 62 FTY# 62 Marqibo 62 TKI therapy 62 PCK# 62 TRISENOX ® 62 SCCHN 62 Hsp# Inhibitor 62 evaluating satraplatin 62 AZX# 62 anti EGFR antibody 62 Specifid 62 veltuzumab 62 gemtuzumab ozogamicin 62 immunomodulatory 62 crizotinib PF # 62 castration resistant prostate cancer 62 Prestara 62 LUX Lung 62 Cimzia ® certolizumab pegol 62 CCX# B 62 cannabinor 62 Phase IIa trial 62 relapsed refractory 62 PROVENGE sipuleucel T 62 Safinamide 62 Uvidem 62 Glypromate 62 Hyphanox 62 budesonide foam 62 elinogrel 62 olaparib 62 samalizumab 62 R roscovitine 62 tremelimumab 62 ONCONASE 62 Lu AA# 62 canakinumab 62 CALGB # [002] 62 JAK inhibitors 62 R# #mg BID 62 erlotinib Tarceva R 62 silodosin 62 imatinib mesylate 62 Dapagliflozin 62 severe hypercholesterolemia 62 TO AVOID PREGNANCY WHILE 62 cetuximab Erbitux 62 afatinib 62 elvucitabine 62 Reverset 62 ZD# [001] 62 BR.# 62 SinuNase ™ 62 cangrelor 62 refractory indolent non 62 Clonicel 62 TYZEKA 62 randomized Phase IIb 62 vinorelbine 62 Neulasta R 62 Cancidas 62 PRTX 62 paclitaxel Taxol R 62 fostamatinib 62 EDEMA3 62 corticosteroid dexamethasone 62 Telintra 62 sorafenib Nexavar ® 62 PSN# [002] 62 AVN# [001] 62 Aliskiren 62 lixisenatide 62 xanthine oxidase inhibitor 62 INCB# [003] 62 MoxDuo IR 62 BioNumerik 62 CRLX# 62 glatiramer acetate 62 Phase 1b 62 Clavis Pharma 62 ribavirin RBV 62 follicular Non Hodgkin 62 Ixempra 62 Triolex 62 telaprevir dosed 62 Entereg R 62 AVOREN 62 Clolar 62 Gleevec imatinib mesylate 62 refractory AML 62 GAMMAGARD 62 favorable tolerability 62 Orphan Drug designations 62 davunetide intranasal AL 62 Peginterferon alfa 2b 62 TLR9 agonist 62 Angiolix 62 G#DT 62 diclofenac sodium 62 Silodosin 62 Cannabinor 62 APEX PD 62 bardoxolone methyl 62 confirmatory Phase III 62 Insegia 62 registrational trial 62 evaluating Xcytrin 62 Loramyc R 62 rifalazil 62 ARIKACE 62 Vidaza R 62 Dalbavancin 62 oral taxane 62 Pegloticase 62 Cotara 62 Phase IIB 62 metastatic colorectal carcinoma 62 VEGF inhibitors 62 systemically administered 62 antibody MAb 62 Phase III randomized controlled 62 edoxaban 62 Cimzia certolizumab pegol 62 LBH# 62 CLARITY study 62 liposomal doxorubicin 62 APTIVUS r 62 TAFA# 62 multicenter Phase III 62 immunomodulator 62 Dr. McHutchison 62 dexanabinol 62 perifosine 62 Zorbtive TM 62 radezolid 62 leading oral taxane 62 hypereosinophilic syndrome 62 Yondelis ® 62 tigecycline 62 Orphan Drug status 62 Ataluren 62 Methylnaltrexone 62 Folotyn 62 ciclesonide 62 noninfectious uveitis 62 MAA submission 62 Proleukin 62 plus DOXIL 62 ALS #-# 62 oral Azacitidine 62 ritonavir boosted 62 DASISION 62 oral FTY# 62 Aclidinium 62 SinuNase 62 panitumumab Vectibix 62 AeroLEF TM 62 phase IIIb 62 eritoran 62 UVIDEM 62 relapsed SCLC 62 HCV SPRINT 62 Gleevec resistant 62 Phase #b/#a trial 62 protease inhibitor PI 62 placebo controlled clinical 62 mesylate 62 plasma kallikrein inhibitor 62 Promacta 62 temsirolimus Torisel ® 62 XL# XL# XL# 62 MIRCERA 62 immunomodulatory properties 62 Phase IIa clinical 62 ELADUR 62 trastuzumab DM1 T DM1 62 catheter occlusion 62 lymphoid malignancies 62 generation purine nucleoside 62 oral methylnaltrexone 62 Mycamine 62 melphalan prednisone 62 Azixa 62 active comparator 62 invasive candidiasis 62 ARIKACE ™ 62 pegfilgrastim 62 romiplostim 62 Pruvel 62 RPL# 62 GEM OS1 62 Trofex 62 XL# XL# XL# XL# 62 Evoltra TM 62 GED aPC 62 tolerability pharmacokinetics 62 Theratope 62 Abiraterone acetate 62 imatinib Gleevec ® 62 cariprazine 62 IMiDs R 62 diarrhea predominant irritable 62 potent antiproliferative 62 EP #R 62 IRESSA 62 APTIVUS 62 Gabapentin GR 62 carboplatin paclitaxel 62 relapsing multiple sclerosis 62 antiarrhythmic 62 Pradefovir 62 Gefitinib 62 balsalazide tablet 62 RoACTEMRA 62 oral picoplatin 62 INCB# [002] 62 Argatroban 62 PRIALT 62 Panzem 62 RAPAFLO 62 PROSTVAC ® 62 SUTENT ® 62 odanacatib 62 Mylotarg 62 Excellarate 62 daptomycin 62 BEMA TM Fentanyl 62 desvenlafaxine 62 Tolvaptan 62 hematologic malignancies 62 custirsen 62 Pralatrexate 62 trodusquemine 62 Emselex 62 Rituxan rituximab 62 muraglitazar 62 haematologic malignancies 62 RhuDex TM 62 gemcitabine chemotherapy 62 taxane chemotherapy 62 Nuvion 62 daclizumab 62 Xcytrin R 62 Augment Injectable 62 biologic DMARD 62 Gleevec Glivec 62 ® bortezomib 62 FOLOTYN 62 cobiprostone 62 menadione 62 Clofarabine 62 telaprevir VX 62 Cytoxan 62 glatiramer

Back to home page